Tag Archives: IBD Research: disease monitoring

Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.

Quantum Blue® Calprotectin Citation: Ferreiro-Iglesias, R. Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE., Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy. J Clin Gastroenterol. 2016 Feb;50(2):147-51. doi: 10.1097/MCG.0000000000000312. “We found FC to be a very accurate
Continue Reading →

Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients with Ulcerative Colitis In Clinical And Endoscopic Remission

BÜHLMANN fCAL® ELISA Citation Guardiola, J, Schatt P, Grimmelprez A, Gohy P, Deltour D, Collard G, Vankerkhoven P.  Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients with Ulcerative Colitis In Clinical And Endoscopic Remission, Clinical Gastroenterology and Hepatology.  2014 Nov;12(11):1865-70. doi: 10.1016/j.cgh.2014.06.020. “…an FC value less than 155 mg/g is a reliable indicator of the
Continue Reading →

Comparison of the Liaison® Calprotectin Kit with a Well-Established Point of Care Test (Quantum Blue — Bühlmann-Alere®) in Terms of Analytical Performances and Ability to Detect Relapses Amongst a Crohn Population in Follow-up

Quantum Blue® Calprotectin Citation: Delefortrie, Q. Schatt P, Grimmelprez A, Gohy P, Deltour D, Collard G, Vankerkhoven P. Comparison of the Liaison® Calprotectin kit with a well-established point of care test (Quantum Blue — Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up, Clinical Biochemistry. 2016 Feb;49(3):268-73. doi: 10.1016/j.clinbiochem.2015.10.010
Continue Reading →

Comparison of Fecal Inflammatory Markers in Crohn’s Disease

BÜHLMANN fCAL® ELISA Citation Wright, E. K., et al., 2016, Comparison of Fecal Inflammatory Markers in Crohn’s Disease, Inflamm Bowel Dis. 2016 May;22(5):1086-94. doi: 10.1097/MIB.0000000000000671. “This study shows that FC is the optimal marker for diagnosing and monitoring endoscopic postoperative Recurrence”. Learn More
Continue Reading →